Back to Results
First PageMeta Content
Daiichi Sankyo / Olmesartan / Azor / Prasugrel / Pravastatin / Angiotensin II receptor antagonist / Warfarin / Ranbaxy Laboratories / Statin / Chemistry / Organic chemistry / Ketones


PowerPoint プレゼンテーション
Add to Reading List

Document Date: 2014-09-21 22:39:50

Open Document

File Size: 893,21 KB

Share Result on Facebook

City

San Francisco / /

Company

ADP / Sankyo / Bn Daiichi Sankyo Group / Eli Lilly / JP Morgan / Daiichi Sankyo / Bn Ranbaxy Group / J&J / /

Continent

North America / Europe / /

Country

Germany / Japan / United States / United Kingdom / India / /

Currency

USD / EUR / JPY / /

Event

FDA Phase / /

IndustryTerm

pharmaceuticals / e-pub / pharmaceutical / /

MedicalCondition

systemic embolism / Stroke / Primary efficacy endpoint Stroke / systemic embolism Stroke / /

Organization

European Union / /

Person

Jokichi Takamine / George Nakayama / /

Position

1st president / President and CEO / /

Product

Levofloxacin / Benicar HCT / Pravachol / Benicar / Azor / Levaquin / Lixiana® / FXa / /

SocialTag